ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹522 Cr | ₹531 Cr | ₹129 Cr | ₹144 Cr | ₹287 Cr |
What is the latest Net Current Assets ratio of ORCHID PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹531 Cr |
| Mar2023 | ₹129 Cr |
| Mar2022 | ₹144 Cr |
| Mar2021 | ₹287 Cr |
How is Net Current Assets of ORCHID PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | -1.70 | |
| Mar2024 | ₹531 Cr | 311.08 | |
| Mar2023 | ₹129 Cr | -10.07 | |
| Mar2022 | ₹144 Cr | -49.96 | |
| Mar2021 | ₹287 Cr | - | |
Compare Net Current Assets of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹4,825.1 Cr | -1.9% | 33.4% | 44.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -1.9% |
33.4% |
44.8% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses